Progyny Beats Expectations with Strong Q3 Results

Progyny, a New York-based fertility benefits provider, reported robust third-quarter results, exceeding Wall Streets expectations with a net income of $13.9 million and adjusted earnings of $0.45 per share. The companys revenue also surpassed forecasts, reaching $313.3 million. Looking ahead, Progyny anticipates earnings per share between $0.37 and $0.40 for the current quarter and $1.79 to $1.82 for the entire fiscal year, indicating continued growth.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.